Central Serous Chorioretinopathy After Scalp And Eyebrow Intralesional Triamcinolone Acetonide Injections: Report Of Two Cases

July 2024 in “ JAAD Case Reports ”

Deesha Desai, Ambika Nohria, Lina Alhanshali, Michael Buontempo, Kristen I. Lo Sicco, Craig M. Fern, Jerry Shapiro

triamcinolone acetonide intralesional triamcinolone acetonide alopecia areata corticosteroids IL-TAC AA

TLDR Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

This report presents two cases of central serous chorioretinopathy (CSC) following intralesional triamcinolone acetonide (IL-TAC) injections for alopecia areata (AA). A 58-year-old female developed CSC after 4 months of IL-TAC treatment, which improved upon dose reduction. A 34-year-old male developed CSC after receiving IL-TAC injections to the scalp and eyebrows, with symptoms resolving upon discontinuation of IL-TAC. These cases highlight a potential link between IL-TAC injections and CSC, suggesting the need for caution and monitoring when using corticosteroids for localized treatments. Further research is needed to understand the mechanisms and risk factors involved.

View this study on jaadcasereports.org →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Central Chorioretinopathy Associated with Topical Use of Minoxidil 2% for Treatment of Baldness

9 citations, September 2011 in “Cutaneous and Ocular Toxicology”

Using 2% minoxidil for baldness treatment might cause vision distortion due to fluid build-up under the retina.

Similar Research

5 / 1000+ results

research Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs

1 citations, March 2023 in “Clinical, Cosmetic and Investigational Dermatology”

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

research Alopecia Areata: A Comprehensive Review of Pathogenesis and Management

99 citations, July 2017 in “Clinical Reviews in Allergy & Immunology”

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

research Medical Therapy for Frontal Fibrosing Alopecia: A Review and Clinical Approach

37 citations, April 2019 in “Journal of The American Academy of Dermatology”

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

research Treatment Options for Alopecia Areata

4 citations, September 2011 in “Expert Review of Dermatology”

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

research Alopecia Areata Update

85 citations, October 2012 in “Dermatologic Clinics”

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.